Industry Symposia

Industry symposia are commercially-supported educational activities held during the ISN World Congress of Nephrology. The symposia are scheduled on Saturday and Sunday from 13:15 – 14:15. One breakfast symposium is scheduled from 07:15 – 08:15 on Sunday. Full details on the symposia programs can be found below and on the Congress app.

Saturday, March 28 – 13:15 - 14:15
Sunday, March 29 – 13:15 - 14:15

Company Room Title Day Time
Astellas Pharma Hall 4A The burden of Anaemia in CKD: Perspectives from Patient Registries Saturday, March 28 13:15 – 14:15
Zydus Capital Suite 7 Zydus Nephrology Symposium on Anemia & Transplant Saturday, March 28 13:15 – 14:15
Terumo BCT Capital Suite 7 Sunday, March 29 07:15 - 08:15
Sanofi Genzyme Conference Hall B2 Genetic Kidney Disease: From innovative diagnosis to new therapeutic targets Saturday, March 28 13:15 – 14:15
Vifor Pharma Conference Hall B2 Sunday, March 29 13:15 – 14:15
Boehringer Ingelheim Hall 4A KDIGO Diabetes in CKD Guideline - Individualizing Patient Care: Looking at the Latest Evidence and Beyond Sunday, March 29 13:15 – 14:15
Baxter Capital Suite 7 Sunday, March 29 13:15 – 14:15

Industry Symposia Program

Saturday, March 28

  • Title: The burden of Anaemia in CKD: Perspectives from Patient Registries
  • Organizer: Astellas
  • Room: Hall 4A
  • Time: 13:15 – 14:15
  • Chair(s): Prof Ziad Massy (France)
  • Schedule:
    Time Title Speaker
    13:15 - 13:20 Introduction and welcome Prof Ziad Massy (France)
    13:20 - 13:40 The Complex Picture of Anaemia in CKD: What Challenges Still Remain? Prof Ziad Massy (France)
    13:40 - 14:00 Anaemia, CKD and Inflammation: Insights from the Swedish Renal Registry Prof Juan-Jesus Carrero (Sweden)
    14:00 - 14:10 Discussion
    14:10 - 14:15 Summary and close Prof Ziad Massy, France
  • Title: Zydus Nephrology Symposium on Anemia & Transplant
  • Organizer: Zydus Nephrosciences, a division of Cadila Healthcare Ltd, India
  • Room: Capital Suite 7
  • Time: 13:15 – 14:15
  • Moderator(s): Dr Sankaran Sundar (India)
  • Chair(s): Dr Nizar Attallah (UAE)
    Prof Vivekanand Jha (UK)
    Prof D S Rana (India)
    Prof Vijay Kher (India)
    Prof A K Bhalla (India)
    Prof R K Sharma (India)
  • Schedule:
    Time Title Speaker(s)
    13:15 - 13:30 Overview of Desidustat – a novel HIF PHI Dr Deven D Parmar (UAE)
    13:30 - 13:35 Q&A
    13:35 - 13:50 Panel Discussion: HIF-PH Inhibitors – A new ray of hope Dr Kevin Kumar Kansagra (India)
    Dr Dinesh Khullar (India)
    Prof Narayan Prasad (India)
    Prof Sanjeev Gulati (India)
    Dr P P Varma (India)
    Dr Sishir Gang (India)
    Prof Santosh Varughese (India)
    13:50 - 13:55 Q&A
    13:55 - 14:10 Depleting antibodies in kidney transplantation with ATLG Prof Ashwani Gupta (India)
    14:10 - 14:15 Q&A
  • Title: Coming soon
  • Organizer: Terumo BCT
  • Room: Conference Hall A
  • Time: 07:15 - 08:15
  • Title: Genetic Kidney Disease: From innovative diagnosis to new therapeutic targets
  • Organizer: Sanofi Genzyme
  • Room: Conference Hall B2
  • Time: 13:15 – 14:15
  • Chair(s): Dr Nizar Attallah (UAE)
  • Schedule:
    Time Title Speaker
    13:15 - 13:20 Introduction and welcome Dr Nizar Attallah (UAE)
    13:20 - 13:45 Epidemiology of monogenic kidney diseases and clinical implications Dr York Pei (Canada)
    13:45 - 14:10 Targeting sphingolipids in rare and common kidney disorders Dr Tomas Natoli (USA)
    14:10 - 14:15 Q&A Dr Nizar Attallah (UAE)

Sunday, March 29

  • Title: KDIGO Diabetes in CKD Guideline - Individualizing Patient Care: Looking at the Latest Evidence and Beyond
  • Organizer: KDIGO, Boehringer Ingelheim
  • Room: Hall 4A
  • Time: 13:15 – 14:15
  • Chair(s): Dr Vlado Perkovic (Australia), Dr David Wheeler (UK)
  • Schedule:
    Time Title Speaker
    13:15 - 13:20 KDIGO Introduction Dr David Wheeler (UK)
    13:20 - 13:40 New KDIGO Guideline on the Management of Diabetes in CKD Dr Peter Rossing (Denmark)
    13:40 - 14:00 Detection, Prevention, and Treatment of CKD in Diabetes Dr Katherine Tuttle (USA)
    14:00 - 14:15 Patient Perspective: The Human Experience of Living with Diabetes and CKD Mrs Tami Sadusky (USA)
  • Title: Long-term potassium control in cardio-renal patients: overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy
  • Organizer: Vifor Pharma
  • Room: Conference Hall B2
  • Time: 13:15 – 14:15
  • Chair(s): Rossignol, Patrick
  • Schedule:
    Time Title Speaker
    13:15 - 13:20 Welcome and introduction Rossignol, Patrick
    13:20 - 13:40 RAAS inhibition in patients with cardiorenal involvement: Balancing the benefits and risks Jardine, Meg
    13:40 - 14:00 New directions in managing the risk of hyperkalaemia Rossignol, Patrick
    13:40 - 14:00 Discussion
    14:00 - 14:15 Summary and close Rossignol, Patrick
Follow via Facebook Follow via Twitter Follow via Google